Fire at Aurobindo Pharma arm Penicillin G facility, no injuries reported
Hyderabad: A fire broke out at Penicillin G manufacturing facility of Lyfius Pharma Private Limited, a subsidiary of Aurobindo Pharma, located in Kakinada SEZ, Thondangi (M), Kakinada District - 533449, Andhra Pradesh, India.
Aurobindo disclosed in a BSE filing that the incident occurred around 10:00 PM (IST) on April 27, 2025, in the vicinity of the coal crusher area.
The fire incident took place due to the self-ignition of coal. The company is in the process of ascertaining the exact reasons for the same.
"The incident is not expected to have material impact on the operations or financials of the group. A thorough assessment of the damage is currently underway," Aurobindo stated.
As a precautionary measure and to facilitate necessary equipment replacements, operations at the plant will be temporarily paused for an estimated period of 20 to 25 days. Aurobindo also reassured stakeholders that the facility is fully insured.
Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries. The company has 30 manufacturing and packaging facilities that are approved by regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. The Company’s product portfolio is spread over seven major therapeutic/product areas encompassing CNS, Anti-Retroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and AntiAllergic, supported by a strong R&D set-up.
